TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 2 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $746 | -26.6% | 1,573 | 0.0% | 0.00% | – |
Q2 2023 | $1,016 | +101500.0% | 1,573 | -2.4% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 1,612 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -100.0% | 1,612 | -83.9% | 0.00% | – |
Q1 2022 | $10,000 | – | 10,041 | +9462.9% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 105 | -90.7% | 0.00% | – |
Q3 2021 | $2,000 | – | 1,134 | +608.8% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 160 | -97.7% | 0.00% | – |
Q1 2021 | $20,000 | -23.1% | 6,821 | -14.4% | 0.00% | -100.0% |
Q4 2020 | $26,000 | – | 7,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 62,333 | $35,000 | 0.00% |
Level Financial Advisors | 987 | $1,000 | 0.00% |
Westside Investment Management, Inc. | 4 | $0 | 0.00% |
American Portfolios Advisors | 23 | $13 | 0.00% |
Renaissance Technologies | 240,710 | $135,000 | 0.00% |
VANGUARD GROUP INC | 74,895 | $42,000 | 0.00% |
Ergoteles LLC | 18,978 | $11,000 | 0.00% |
UBS Group AG | 26,945 | $15,000 | 0.00% |
IFP Advisors, Inc | 844 | $3,000 | 0.00% |
OSAIC HOLDINGS, INC. | 14 | $0 | 0.00% |